Pembrolizumab-induced myocarditis with complete atrioventricular block and concomitant myositis in a metastatic bladder cancer patient: a case report and review of the literature.
R SaadA GhaddarRony M ZeennyPublished in: Journal of medical case reports (2024)
Life-threatening cardiac adverse events in the form of myocarditis may occur with pembrolizumab use, warranting vigilant cardiac monitoring. Troponin monitoring in high-risk patients, along with baseline echocardiography may help identify this complication promptly to prevent life-threatening consequences.
Keyphrases
- left ventricular
- end stage renal disease
- ejection fraction
- chronic kidney disease
- squamous cell carcinoma
- advanced non small cell lung cancer
- small cell lung cancer
- computed tomography
- pulmonary hypertension
- case report
- high glucose
- peritoneal dialysis
- rheumatoid arthritis
- drug induced
- patient reported
- endothelial cells